TIS chart has caught my attention again... So I ducked off to do a bit of read through the anns...
Seem to be a bit light on info this year... Actually its pretty poor...
It would appear that
1. CE approval is a certainty
2. Once approved use of the product is a certainty
3. They have the people in place to get the ball moving
4. Vitrogro wins hands down in its efficacy and cost to use
5. However nothing on potential sales...
Once CE approval then what? What sort of sales predictions are they modelling their current inventory around????
How many units do they expect to penetrate the market with this financial year????
But my big question is how much $$$$ is predicted to flow back into TIS and its shareholders????
TIS chart has caught my attention again... So I ducked off to do...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)